The present invention relates to the field of stable
biopolymer compositions, in particular to stable
biopolymer compositions comprising a liquid mixture, in particular an
aqueous solution, of at least one
biopolymer component and at least one stabilizing surfactant. More specifically, the present invention relates to a stable biopolymer composition comprising an
ethylene oxide / butylene
oxide block
copolymer capable of imparting superior properties to said biopolymer composition, in particular in terms of aggregation tendency, hemolytic activity and
solubility, compared to currently known formulations. The invention also relates to said block
copolymer, to a method for preparing said stable composition and to the use of said block
copolymer for stabilizing an aqueous composition of said biopolymer. The invention also relates to said stable composition for use in
medicine, in particular for diagnostic and / or therapeutic applications. The invention also relates to a substantially dry biopolymer composition comprising the biopolymer and the block copolymer, and to a process for preparing the substantially dry composition. The invention also relates to said substantially dry biopolymer composition for use in
medicine, in particular for diagnostic and / or therapeutic applications. The compositions can be formulated as pharmaceutical compositions that can be delivered by suitable routes of administration, such as by
oral administration,
rectal administration, transmucosal administration, topical administration, ocular administration, aural administration, or
enteral administration; parenteral delivery, including
intramuscular injection,
subcutaneous injection, intramedullary injection, and
intrathecal injection, direct intraventricular injection, intravenous injection,
intraperitoneal injection, intranasal injection, or intraocular injection, depending on conditions.